Suppr超能文献

对于早期胰腺导管腺癌,在胰十二指肠切除术后,静脉壁侵犯比静脉切缘对肿瘤学结局的预测更可靠。

Vein Wall Invasion Is a More Reliable Predictor of Oncological Outcomes than Vein-Related Margins after Pancreaticoduodenectomy for Early Stages of Pancreatic Ductal Adenocarcinoma.

作者信息

Ahuja Manish, Pandé Rupaly, Chugtai Shafiq, Brown Rachel M, Cain Owen, Bartlett David C, Dasari Bobby V M, Marudanayagam Ravi, Roberts Keith J, Isaac John, Sutcliffe Robert P, Chatzizacharias Nikolaos

机构信息

Department of HPB and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

Department of Pathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UK.

出版信息

Diagnostics (Basel). 2023 Nov 17;13(22):3465. doi: 10.3390/diagnostics13223465.

Abstract

Pancreaticoduodenectomy (PD) with vein resection is the only potentially curative option for patients with pancreatic ductal adenocarcinoma (PDAC) with venous involvement. The aim of our study was to assess the oncological prognostic significance of the different variables of venous involvement in patients undergoing PD for resectable and borderline-resectable with venous-only involvement (BR-V) PDAC. We performed a retrospective analysis of prospectively acquired data over a 10-year period. Of the 372 patients included, 105 (28%) required vein resection and vein wall involvement was identified in 37% of those. A multivariable analysis failed to identify the vein-related resection margins as independent predictors for OS, DFS or LR. Vein wall tumour involvement was an independent predictor of OS (risk x1.7-2) and DFS (risk x1.9-2.2) in all models, while it replaced overall surgical margin positivity as the only parameter independently predicting LR during an analysis of separate resection margins (risk x2.4). Vein wall tumour invasion may be a more reliable predictor of oncological outcomes compared to traditionally reported parameters. Future studies should focus on possible pre-operative investigations that could identify these cases and management pathways that could yield a survival benefit, such as the use of neoadjuvant treatments.

摘要

对于伴有静脉侵犯的胰腺导管腺癌(PDAC)患者,行静脉切除的胰十二指肠切除术(PD)是唯一可能治愈的选择。我们研究的目的是评估仅伴有静脉侵犯(BR-V)的可切除及交界可切除PDAC患者在接受PD手术时,静脉侵犯的不同变量对肿瘤学预后的意义。我们对前瞻性收集的10年数据进行了回顾性分析。在纳入的372例患者中,105例(28%)需要行静脉切除,其中37%存在静脉壁侵犯。多变量分析未能将与静脉相关的切缘确定为总生存期(OS)、无病生存期(DFS)或局部复发(LR)的独立预测因素。在所有模型中,静脉壁肿瘤侵犯是OS(风险×1.7 - 2)和DFS(风险×1.9 - 2.2)的独立预测因素,而在单独分析切缘时,它取代了手术切缘阳性成为独立预测LR的唯一参数(风险×2.4)。与传统报道的参数相比,静脉壁肿瘤侵犯可能是肿瘤学结局更可靠的预测因素。未来的研究应关注可能识别这些病例的术前检查以及可能带来生存获益的管理途径,如新辅助治疗的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1044/10670022/a779f93c48dd/diagnostics-13-03465-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验